Prostate and Genitourinary Cancer Program

Director: James B. Yu, MD

emptyThe Prostate and Genitourinary Cancer Program at the Smilow Cancer Center at Yale-New Haven is at the forefront of cutting edge cancer care. Offering ultrasound guided transperineal prostate brachytherapy, Image Guided – Intensity Modulated Radiation Therapy, and Calypso radiofrequency beacon guided- Intensity Modulated Radiation Therapy, the Prostate and Genitourinary Radiotherapy program at Smilow Cancer Center provides nationally recognized and evidence based radiotherapy care in a caring and personalized environment.

The past decade has brought about major changes in the way radiotherapy is delivered for prostate cancer. Foremost among these changes is the development of Intensity Modulated Radiation Therapy (IMRT), allowing the precise shaping of radiation dose around the prostate, with corresponding better avoidance of surrounding critical structures, such as the rectum and bladder. The Yale prostate IMRT program has become one of the most respected prostate radiotherapy programs in the country. We are able to precisely account for daily set up error and patient positioning with daily 3-Dimensional imaging and reconstruction of the prostate and surrounding tissues using cone-beam technology. Further, we are able to track the motion o the prostate using real-time radio guidance using implanted radiorequency beacons-known as the Calypso system.

Together with our proven and well-published experience in prostate radiotherapy, and our research into the comparative effectiveness of new radiation technologies for prostate cancer, Yale New Haven Hospital is a true National and International leader in prostate radiotherapy.